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Abstract: Marine macrophytes contain a variety of biologically active compounds, some 
reported to have antiprotozoal activity in vitro. As a part of a screening program to search 
for new natural antiprotozoals, we screened hydroalcoholic and ethyl acetate extracts of  
20  species  of  seaweeds  from  three  phyla  (Rhodophyta,  Heterokontophyta  and 
Chlorophyta), sampled along the Normandy (France) coast. We tested them in vitro against 
the  protozoa  responsible  for  three  major  endemic  parasitic  diseases:  Plasmodium 
falciparum, Leishmania donovani and Trypanosoma cruzi. The selectivity of the extracts 
was also evaluated by testing on a mammalian cell line (L6 cells). Ethyl acetate extracts 
were more active than hydroalcoholic ones. Activity against T. cruzi and L. donovani was 
non-existent  to  average,  but  almost  half  the  extracts  showed  good  activity  against  P. 
falciparum.  The  ethyl  acetate  extract  of  Mastocarpus  stellatus  showed  the  best 
antiplasmodial activity as well as the best selectivity index (IC50 = 2.8 µ g/mL; SI > 30). 
Interestingly, a red algae species, which shares phylogenetic origins with P. falciparum, 
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showed  the  best  antiplasmodial  activity.  This  study  is  the  first  to  report  comparative 
antiprotozoal activity of French marine algae. Some of the species studied here have not 
previously been biologically evaluated. 
Keywords:  seaweeds;  Phaeophyceae;  Rhodophyceae;  Plasmodium;  Trypanosoma; 
Leishmania 
 
1. Introduction 
Protozoal  diseases,  especially  malaria,  leishmaniasis,  and  Chagas  disease,  are  major  causes  of 
mortality in various tropical and subtropical regions [1]. Moreover, treatment failure is increasingly 
common with current drugs. The resistance of Plasmodium falciparum, for example, to the former 
first-line antimalarials, chloroquine and sulfadoxine/pyrimethamine, has reached critical levels in many 
malaria-endemic regions and is producing deleterious effects on human health, wealth, and lifespans. 
Recent  reports  that  malaria  parasites  have  begun  to  develop  tolerance  to  the  artemisinin-based 
combination  therapies  threaten  the  last  mainstay  for  treating  uncomplicated  malaria  in  endemic 
countries [2,3]. Furthermore, no new class of antimalarials has been introduced into clinical practice 
since 1996 [4]. Worse, chemotherapy of visceral leishmaniasis and Chagas disease still relies on first-line 
drugs that are old and far from satisfactory because of their major side effects, limited efficacy, and 
difficulty of administration. New more effective chemotherapeutic agents with novel modes of action 
are needed, and marine biodiversity might be a source of chemodiversity for that purpose. 
Marine biodiversity contains resources composed of a variety of biologically active compounds [5–7]. 
Marine  macrophytes  produce  an  array  of  secondary  compounds  [8]  still  underexploited  for  their 
biomedical  potential  although  they  are  a  particularly  available  biomass.  Studies  of  tropical  marine 
macrophytes have shown their extensive biological activity, including antiprotozoal [9–12], but very 
little is known about Western seaweed species. 
As a part of a screening program to search for new natural antiprotozoal products, we report here 
the in vitro screening of 35 polar (hydroalcoholic) and apolar (ethyl acetate) extracts from 20 species 
of  seaweeds  from  the  Normandy  (France)  coast  against  cultured  protozoa  responsible  for  human 
malaria, visceral leishmaniasis, and Chagas disease. 
2. Results and Discussion 
The sampling resulted in the selection of 20 species of seaweeds that were brown (8), red (9) and 
green algae (3). The species were collected from rocky habitats along the Normandy coast in northern 
France (Table 1). 
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Table  1.  Marine  algal  species  selected  for  the  study,  and  the  sites  and  times  of  their 
collection (Normandy coast, France). 
Species  Family  Collection site  Collection time 
Chlorophyta 
Codium tomentosum Stackhouse 
Ulva lactuca (Linnaeus) 
Ulva clathrata (Roth) C. Agardh 
 
Heterokontophyta 
Bifurcaria bifurcata R. Ross 
Dictyopteris polypodioides (A.P. de Candolle) 
J.V. Lamouroux 
Dictyota dichotoma (Hudson) J.V. Lamouroux 
Fucus serratus (Linnaeus) 
Himanthalia elongata (Linnaeus) 
Laminaria digitata (Linnaeus) J.V. Lamouroux 
Pelvetia canaliculata Decaisne & Thuret 
Sargassum muticum (Yendo) Fensholt 
 
Rhodophyta 
Calliblepharis jubata (Goodenough & 
woodward) Kü tzing  
Chondrus crispus Stackhouse 
Dilsea carnosa (Schmidel) Kuntze 
Gelidium latifolium Bornet ex Hauck  
Gracilaria gracilis (Stackhouse) Steentoft, L.M. 
Irvine & Farnham 
Grateloupia turuturu Yamada 
Halurus flosculosus (J. Ellis) Maggs & 
Hommersand 
Mastocarpus stellatus (Stackhouse) Guiry 
Palmaria palmata (Linnaeus) Kuntze 
 
Codiaceae 
Ulvaceae 
Ulvaceae 
 
 
Sargassaceae 
Dictyotaceae 
 
Dictyotaceae 
Fucaceae 
Himanthaliaceae 
Laminariaceae 
Fucaceae 
Sargassaceae 
 
 
Cystocloniaceae 
 
Gigartinaceae 
Dumontiaceae 
Gelidiaceae 
Gracilariaceae 
 
Halymeniaceae 
Ceramiaceae 
 
Phyllophoraceae 
Palmariaceae 
 
Cap Lé vy (Manche) 
Luc-sur-Mer (Calvados) 
Anse St Martin (Manche) 
 
 
Cap Lé vy (Manche) 
Barneville (Calvados) 
 
Anse St Martin (Manche) 
Luc-sur-mer (Calvados) 
Cap Lé vy (Manche) 
Langrunes-sur-Mer (Calvados) 
Cap Lé vy (Manche) 
Cap Lé vy (Manche) 
 
 
Cap Lé vy (Manche) 
 
Cap Lé vy (Manche) 
Langrune-sur-Mer (Calvados) 
Cap Lé vy (Manche) 
Anse St Martin (Manche) 
 
St Vaast-la-Hougue (Manche) 
Anse St Martin (Manche) 
 
Cap Lé vy (Manche) 
Luc-sur-Mer (Calvados) 
 
June 2007 
October 2006 
June 2007 
 
 
June 2007 
October 2007 
June 2007 
June 2007 
November 2005 
June 2006 
January 2007 
June 2006 
June 2006 
 
 
June 2007 
 
June 2007 
January 2007 
June 2006 
June 2007 
 
September 2007 
June 2007 
 
June 2006 
November 2005 
The potential antiplasmodial activity of the resultant ethyl acetate and hydroalcoholic extracts was 
evaluated in vitro against erythrocytes infected by a resistant K1 strain of P. falciparum, as well as 
against T. cruzi trypomastigotes and Leishmania donovani amastigotes (Table 2). Extracts were first 
screened at two concentrations (1.6 and 9.7 µg/mL), and parasite growth inhibition was measured. 
Extracts for which parasite growth inhibition was greater than 50% at the concentration of 9.7 µg/mL 
were subsequently assayed to determine their IC50. An extract was considered as active if the IC50 
value was less than 5 µ g/mL. Cytotoxicity to primary mammalian L6 cells was also evaluated to 
determine the selectivity of its activity. Table 3 presents the IC50 values and selectivity indexes (ratio 
of cytotoxic to antiprotozoal activity). 
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Table 2. In vitro antiprotozoal medium throughput screening of extracts obtained from the 
selected species. P. falciparum: Multidrug-resistant K1 strain erythrocytic stages; T. cruzi: 
Talahuen  strain  trypomastigotes;  L.  donovani:  MHOM/ET/67/L82  strain  axenic 
amastigotes.  (E):  EtOH  60%  extract,  (A):  ethyl  acetate  extract,  nd:  not  determined. 
Compounds for which parasite growth inhibition was greater than 50% at 9.7 µg/mL were 
assayed to determine IC50 and evaluate cytotoxicity. 
      Parasite growth inhibition (%) 
   
  P. falciparum 
Erythrocytic stages 
 
  T. cruzi 
Trypomastigotes 
 
L. donovani 
Axenic amastigotes 
Species  Extract 
  1.6 
µ g/mL 
9.7 
µ g/mL 
 
  1.6 
µ g/mL 
9.7 
µ g/mL 
 
1.6 
µ g/mL 
9.7 
µ g/mL 
B. bifurcata 
 
C. jubata 
 
C. tomentosum 
 
C. crispus 
 
D. polypodioides 
 
D. dichotoma 
 
D. carnosa 
 
F. serratus 
 
G. latifolium 
 
G. gracilis 
 
G. turuturu 
 
H. flosculosus 
 
H. elongata 
 
L. digitata 
 
M. stellatus 
 
P. palmata 
 
P. canaliculata 
 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
E 
A 
  0 
36 
0 
3 
0 
0 
0 
28 
nd 
8 
nd 
19 
0 
9 
0 
0 
nd 
1 
0 
5 
nd 
42 
nd 
19 
0 
14 
0 
0 
0 
42 
0 
0 
15 
0 
25 
100 
0 
71 
2 
0 
0 
92 
 
81 
 
98 
6 
71 
0 
42 
 
93 
0 
92 
 
97 
 
94 
5 
81 
0 
64 
0 
94 
0 
1 
30 
41 
 
  18 
0 
11 
19 
0 
0 
0 
1 
 
6 
 
21 
0 
10 
0 
0 
 
0 
0 
0 
 
15 
 
17 
17 
0 
0 
0 
0 
8 
0 
17 
0 
0 
0 
78 
0 
0 
0 
0 
0 
0 
 
7 
 
17 
0 
14 
0 
3 
 
0 
9 
0 
 
14 
 
21 
13 
18 
9 
3 
4 
0 
0 
36 
0 
13 
 
16 
31 
13 
20 
15 
0 
13 
0 
 
14 
 
27 
0 
9 
0 
0 
 
18 
21 
19 
 
9 
 
22 
20 
13 
0 
0 
11 
22 
0 
0 
7 
14 
40 
100 
34 
40 
29 
0 
95 
12 
 
41 
 
83 
15 
31 
15 
14 
 
49 
29 
36 
 
33 
 
49 
40 
43 
11 
8 
20 
39 
0 
10 
32 
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Table 2. Cont. 
S. muticum 
 
U. lactuca 
 
U. clathrata 
 
E 
A 
E 
A 
E 
A 
  0 
50 
0 
0 
0 
0 
0 
96 
0 
28 
0 
13 
 
  0 
0 
0 
0 
0 
0 
1 
9 
3 
0 
0 
0 
 
8 
4 
0 
0 
0 
0 
37 
48 
26 
11 
0 
7 
Standard drugs   
  0.003 
µ g/mL 
0.018 
µ g/mL 
 
  0.5 
µ g/mL 
2.4 
µ g/mL 
 
0.2 
µ g/mL 
1.2 
µ g/mL 
Artemisinin 
Benznidazole 
Miltefosine 
 
 
 
  68 
 
 
100 
 
 
 
   
45 
 
 
91 
 
 
 
 
59 
 
 
85 
The active extracts were almost entirely ( 97%)  ethyl acetate  extracts,  while the  hydroalcoholic 
extracts were mainly inactive. This finding suggests that the active antiprotozoal  compounds were 
relatively apolar, except for the hydroalcoholic extract of  C. crispus, which was quite active against 
L. donovani (95% inhibition of parasite growth at 9.7 µg/mL). 
Table 3. In vitro antiprotozoal and cytotoxic activities of the active ethyl acetate extracts. 
Data shown are means of two independent assays. SI: selectivity index, ratio of cytotoxic 
activity on L6 cells to the best antiprotozoal activity measured, that is, to antiplasmodial 
(SI
a) or leishmanicidal (SI
b) activity; nd: not determined. 
  IC50 (µg/mL)    Selectivity index (SI) 
  Antiprotozoal activity    Cytotoxic activity     
Species  P. falciparum  L. donovani    L6 cells     
B. bifurcata 
C. jubata 
C. crispus 
D. polypodioides 
D. dichotoma 
D. carnosa 
G. latifolium 
G. gracilis 
G. turuturu 
H. flosculosus 
H. elongata 
M. stellatus 
P. canaliculata 
S. muticum 
 
Standards 
>5 
5 
2.9 
nd 
3.1 
3.9 
3.4 
3.3 
3.1 
4.6 
3.5 
2.8 
nd 
2.9 
3.8 
nd 
nd 
10.8 
8.8 
9.5 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
nd 
  6 
71 
84 
87 
27 
74 
62 
71 
71 
58 
88 
>90 
87 
63 
  1.6 
b 
14 
a 
29
 a 
8 
b 
9
 a 
19
 a 
18
 a 
21
 a 
23
 a 
12
 a 
25
 a 
>30
 a 
11
 a 
11
 a 
Chloroquine  0.069  -    -    - 
Miltefosine  -  0.181    -    - 
Podophyllotoxin  -  -    0.007    - Mar. Drugs 2011, 9                      
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P. falciparum was the pathogen most responsive to these extracts: 40% of the extracts showed 
activity against this protozoon. L. donovani was less sensitive (11% of the extracts were active against 
it) and T. cruzi quite insensitive (3%). Red and brown seaweeds were almost equally active against 
P. falciparum and L. donovani, but green seaweeds were inactive (Figure 1). 
Figure 1. Percentage of extracts active against the protozoan parasites tested. 
 
 
Few studies have reported antiprotozoal screening of marine algae, and those that did looked at 
tropical and Asian species [13,14], most often individually [5,6]. Trypanocidal and leishmanicidal 
activity was recently assessed in British and Irish species [15,16]. Those studies found that organic 
extracts from several British green algae species were active, although weakly, against the same strains 
of T. cruzi and L. donovani that we used here [16]. U. lactuca, the only green algae common to their 
study  and  ours,  was  inactive  in  ours  at  9.7  µg/mL,  despite  similar  experimental  conditions.  This 
discrepancy may stem either from the different extraction solvents or from their different phytochemical 
compositions, probably due to the different habitats of the two samples. 
Brown tropical algae have previously been shown to be moderately active against L. mexicana 
promastigotes, while red and green algal organic extracts were almost inactive, as in our study [14]. 
Here, the most active extract against L. donovani axenic amastigotes was the ethyl acetate extract of 
B. bifurcata, which had an IC50 value of 3.9 µg/mL. Nevertheless, the selectivity index of 1.6 found for 
this extract seems to indicate general toxicity. Moreover, crude organic extracts of Irish B. bifurcata 
were recently shown to be active against both L. donovani and T. brucei rhodesiense, the protozoan 
parasite responsible for sleeping sickness [15]. B. bifurcata contains arrays of terpenoids [17–19] with 
cytotoxic  activity  [19,20].  The  ethyl  acetate  that  we  used  here  efficiently  extracts  this  type  of 
compound. Their presence could explain the absence of selectivity. 
Our  results  provide  further  evidence  that  marine  seaweeds  may  be  active  against  protozoa, 
especially  Plasmodium  species.  Investigations  of  red  algae  species  are  rare,  still  more  so  against 
0
5
10
15
20
25
30
35
40
45
P. falciparum L. donovani T. cruzi
%
 
o
f
 
a
c
t
i
v
e
 
e
x
t
r
a
c
t
s Total active extracts
Rhodophyta active extracts
Heterokontophyta active 
extracts
Chlorophyta active extractsMar. Drugs 2011, 9                      
 
 
928 
P. falciparum. We showed here, for the first time, in vitro antiplasmodial activity by eight French 
species  of  red  algae:  C.  jubata,  C.  crispus,  D.  carnosa,  G.  latifolium,  G.  gracilis,  G.  turuturu, 
H. flosculosus, and M. stellatus. Moreover, the IC50 values measured for these extracts reflect activity 
similar to that reported for such reference extracts as ethanolic crude extracts of Artemisia annua 
(Quinguao) and of Azadirachta indica (Neem) in the same in vitro microdilution test under similar 
experimental conditions [21,22]. 
Interestingly,  Plasmodium  parasites  contain  a  cellular  peculiarity,  called  the  apicoplast,  a 
rudimentary plastid that was acquired long ago by secondary endosymbiosis between a free-living 
ancestor of Apicomplexans and a red algal species [23]. Accordingly, this organelle probably shares 
several metabolic pathways and housekeeping processes with red algae. We can hypothesize that some 
algal compounds contained in these extracts kill malaria parasites by interfering with these common 
pathways or processes. 
The most active and interesting extract was the ethyl acetate extract of M. stellatus, which had the 
best IC50 and SI values (2.8 µg/mL and >30, respectively). Its selectivity towards P. falciparum was 
also  good,  compared  with  the  other  protozoan  parasites  we  tested.  To  our  knowledge,  no 
antiplasmodial activity has previously been shown for Mastocarpus species. Moreover, phytochemical 
data for these genera are sparse. Nevertheless, some tropical species of red algae have been shown to 
contain  such  antiplasmodial  compounds  as  halogenated  diterpenes  [6]  or  bromophycolides  [5,24]. 
Bioguided  fractionation  associated  with  dereplication  techniques  should  allow  us  to  identify  new 
antiplasmodial compounds from this species and thus help us to determine its mode of action. 
3. Experimental Section 
3.1. Algae Collection and Identification 
The  20  algae  species  were  collected  between  November  2005  and  September  2007  at  several 
locations on the coast of Basse-Normandie. Table 1 reports the collection dates and sites. 
Taxonomic determination was performed by Dr. A.-M. Rusig and voucher specimens of the algae are 
deposited in the Herbarium of the University of Caen. 
3.2. Preparation of Crude Extracts 
Freeze-dried algal material of each species (200 g) was powdered and stirred overnight at room 
temperature for complete extraction, with 70% EtOH or ethyl acetate (10%, w/v). The filtrates were 
dried under vacuum at 35 ° C and the residues were stored at 4 ° C until testing. Tannins were removed 
from the crude hydroalcoholic extracts with Sephadex LH-20 exclusion chromatography, according to 
the method described by Houghton and Raman [25]. 
3.3. In Vitro Antiprotozoal Assays 
The extracts were dissolved in dimethylsulfoxide (DMSO) to obtain a concentration of 10 mg/mL 
and screened for antiprotozoal activity against P. falciparum, T. cruzi and L. donovani and cytotoxicity 
against rat skeletal muscle myoblasts (L-6 cells). The in vitro assays were conducted as described by 
Scala et al. [26]. A brief description is given below. Mar. Drugs 2011, 9                      
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3.3.1. Activity against P. Falciparum 
In  vitro  activity  against  erythrocytic  stages  of  P.  falciparum  was  determined  by  a  modified  
[
3H]-hypoxanthine  incorporation  assay  with  the  chloroquine-  and  pyrimethamine-resistant  K1  
strain [27]. Briefly, parasite cultures incubated in RPMI 1640 medium with 5% Albumax (without 
hypoxanthine) were exposed to serial drug dilutions in microtiter plates. After 48 h of incubation at  
37 ° C in a reduced oxygen atmosphere, 0.5 µCi [
3H]-hypoxanthine was added to each well. Cultures 
were incubated for a further 24 h before they were harvested onto glass-fiber filters and washed with 
distilled water. The radioactivity was counted with a BetaplateTM liquid scintillation counter (Wallac, 
Zurich, Switzerland). The results were recorded as counts per minute (CPM) per well at each drug 
concentration and expressed as the percentage of untreated controls. IC50 values were calculated from 
graphically  plotted  dose-response  curves  by  linear  interpolation.  Chloroquine  (Sigma  C6628)  and 
artemisinin (Sigma 36,159-3) were used as positive references. 
3.3.2. Activity against Trypanosoma cruzi 
Rat skeletal myoblasts (L6 cells) were seeded in 96-well microtiter plates at 2000 cells/well in  
100 μL RPMI 1640 medium with 10% FBS and 2 mM  L-glutamine. After 24 h the medium was 
removed and replaced by 100 μL per well containing 5000 trypomastigote forms of T. cruzi Tulahuen 
strain C2C4 with the β-galactosidase (Lac Z) gene [28]. After 48 h, the medium was removed from the 
wells and replaced by 100 μL fresh medium with or without a serial drug dilution of seven 3-fold 
dilution steps covering a range from 90 to 0.123 μg/mL. After 96 h of incubation the plates were 
inspected  under  an  inverted  microscope  to  assure  growth  of  the  controls  and  sterility.  Then  the 
substrate CPRG/Nonidet (50 μL) was added to all wells. A color reaction developed within 2–6 h and 
could  be  read  photometrically  at  540  nm.  The  IC50  values  were  calculated  from  the  sigmoidal 
inhibition curves with SoftmaxPro software. Benznidazole (Roche) was used as a positive reference. 
3.3.3. Activity against Leishmania Donovani 
Amastigotes of L. donovani strain MHOM/ET/67/L82 were grown in axenic culture at 37 ° C in SM 
medium at pH 5.4 supplemented with 10% heat-inactivated fetal bovine serum under an atmosphere of 
5% CO2 in air. Culture medium (100 L) was seeded in 96-well microtiter plates with 10
5 amastigotes 
from axenic culture with or without a serial drug dilution. Serial drug dilutions covering a range from 
90 to 0.123 μg/mL were prepared. After 72 h of incubation the plates were inspected under an inverted 
microscope to assure growth of the controls and sterile conditions. Then 10 µL of a resazurin solution 
(12.5 mg resazurin dissolved in 100 mL double-distilled water) was added to each well, and the plates 
incubated for another 2 h. They were then read in a Spectramax Gemini XS microplate fluorometer at 
an excitation wavelength of 536 nm and an emission wavelength of 588 nm. The IC50 values were 
calculated  from  the  sigmoidal  inhibition  curves  with  SoftmaxPro  software.  Miltefosin  (Zentaris 
GmbH, Germany) was used as a positive reference. 
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3.4. Cytotoxicity against L6 cells 
Assays were performed in 96-well microtiter plates, each well containing 100 L of RPMI 1640 medium 
supplemented with 1% L-glutamine (200 mM) and 10% fetal bovine serum, and 4 ×  10
4 L-6 cells (rat 
skeletal myoblasts). Serial drug dilutions of seven 3-fold dilution steps covering a range from 90 to 
0.123 μg/mL were prepared. After 72 h of incubation the plates were inspected under an inverted 
microscope to assure growth of the controls and sterile conditions. Then 10 μL of a resazurin solution 
(12.5  mg  resazurin  dissolved  in  100  mL  distilled  water)  was  added  to  each  well  and  the  plates 
incubated for another 2 h. They were then read with a Spectramax Gemini XS microplate fluorometer 
at an excitation wavelength of 536 nm and an emission wavelength of 588 nm. The IC50 values were 
calculated from the sigmoidal inhibition curves with SoftmaxPro software. Podophyllotoxin (Sigma, 
P4405) was used as a positive reference. 
3.5. Calculation of IC50 
To  measure  antiplasmodial  activity,  the  concentration  of  extract  at  which  the  parasite  growth 
(=[
3H]hypoxanthine  uptake)  was  inhibited  by  50%  (IC50)  was  calculated  by  linear  interpolation 
between  the  two  concentrations  above  and  below  50%  [29].  To  assess  leishmanicidal, 
antitrypanosomal, and cytotoxic activity we transferred data into the graphic Softmax Pro program 
(Molecular Devices), which calculated IC50 values from the sigmoidal inhibition curve. The values 
given in Table 3 are the means of two independent assays. 
3.6. Selectivity Index Determination 
The selectivity index (SI) corresponds to the ratio of the IC50 value of the cytotoxic activity to the 
IC50 value of antiprotozoal activity. An SI value >10 is generally considered to indicate antiprotozoal 
activity not due to general cytotoxicity. 
4. Conclusions 
Almost all the marine macrophytes species tested in the current study showed activity against at 
least one protozoan. Some of them may be promising sources for further bio-guided isolation of new 
active components. Most of these components are probably apolar compounds. The most interesting 
species, in terms of antiplasmodial activity and selectivity, is the red algae M. stellatus. Bioguided 
fractionation is underway. 
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